Menu
Back to Journals » Hepatic Medicine: Evidence and Research » Volume 10
Hepatic Medicine: Evidence and Research
ISSN: 1179-1535
- View all (188)
- Volume 16, 2024 (3)
- Volume 15, 2023 (22)
- Volume 14, 2022 (13)
- Volume 13, 2021 (16)
- Volume 12, 2020 (16)
- Volume 11, 2019 (16)
- Volume 10, 2018 (13)
- Volume 9, 2017 (10)
- Volume 8, 2016 (15)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5, 2013 (7)
- Volume 4, 2012 (7)
- Volume 3, 2011 (14)
- Volume 2, 2010 (14)
- Volume 1, 2009 (2)
Archive: Volume 10, 2018
Comparison of extracorporeal cellular therapy (ELAD®) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure
Duan Z, Xin S, Zhang J, You S, Chen Y, Liu H, Zheng S, Li Z, Ashley R, Millis M
Hepatic Medicine: Evidence and Research 2018, 10:139-152
Published Date: 16 November 2018
Universal Index for Cirrhosis (UIC index): The development and validation of a novel index to predict advanced liver disease
Ahmed Z, Ren J, Gonzalez A, Ahmed U, Walayat S, Martin DK, Moole H, Yong S, Koppe S, Dhillon S
Hepatic Medicine: Evidence and Research 2018, 10:133-138
Published Date: 24 October 2018
Expert opinion on the management of hepatitis C infection in Kuwait
Saad MF, Alenezi S, Asker H
Hepatic Medicine: Evidence and Research 2018, 10:117-132
Published Date: 28 September 2018
Acute pediatric hyperammonemia: current diagnosis and management strategies
Savy N, Brossier D, Brunel-Guitton C, Ducharme-Crevier L, Du Pont-Thibodeau G, Jouvet P
Hepatic Medicine: Evidence and Research 2018, 10:105-115
Published Date: 12 September 2018
Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
Gunaydin M, Bozkurter Cil AT
Hepatic Medicine: Evidence and Research 2018, 10:95-104
Published Date: 10 September 2018
Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications
Tawfik AK, Helmy A, Yousef M, Abou-Saif S, Kobtan A, Asaad E, Abd-Elsalam S
Hepatic Medicine: Evidence and Research 2018, 10:87-93
Published Date: 4 September 2018
Hepatitis C in Lebanon: the burden of the disease and the value of comprehensive screening and treatment
Abou Rached A, Abou Kheir S, Saba J, Assaf S, Kassis G, Sanchez Gonzalez Y, Ethgen O
Hepatic Medicine: Evidence and Research 2018, 10:73-85
Published Date: 28 August 2018
Management of refractory cirrhotic ascites: challenges and solutions
Fukui H, Kawaratani H, Kaji K, Takaya H, Yoshiji H
Hepatic Medicine: Evidence and Research 2018, 10:55-71
Published Date: 3 July 2018
Biomarkers for primary biliary cholangitis: current perspectives
Kouroumalis E, Samonakis D, Voumvouraki A
Hepatic Medicine: Evidence and Research 2018, 10:43-53
Published Date: 18 June 2018
Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy
Sulejmani N, Jafri SM
Hepatic Medicine: Evidence and Research 2018, 10:33-42
Published Date: 4 May 2018
Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial
Alam S, Ghosh J, Mustafa G, Kamal M, Ahmad N
Hepatic Medicine: Evidence and Research 2018, 10:23-31
Published Date: 27 April 2018
Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
Mendes LC, Stucchi RSB, Vigani AG
Hepatic Medicine: Evidence and Research 2018, 10:13-22
Published Date: 3 April 2018
Hepatic encephalopathy: current challenges and future prospects
Swaminathan M, Ellul MA, Cross TJS
Hepatic Medicine: Evidence and Research 2018, 10:1-11
Published Date: 22 March 2018